[{"Assets_0_Q2_USD":86537000.0,"CommonStockSharesOutstanding_0_Q2_shares":113362000.0,"EarningsPerShareBasic_1_Q2_USD":0.11,"EarningsPerShareBasic_2_Q2_USD":0.15,"EarningsPerShareDiluted_1_Q2_USD":0.1,"EarningsPerShareDiluted_2_Q2_USD":0.14,"NetIncomeLoss_1_Q2_USD":12647000.0,"NetIncomeLoss_2_Q2_USD":17035000.0,"StockholdersEquity_0_Q2_USD":66145000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":123011000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":122171000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":113249000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":113059000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170802"}]